BIOGEN INC. BIIB on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0000875045
0000875045
EIN:
33-0112644
33-0112644
LEI:
(CF Office: 03 Life Sciences)
Business address:
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Phone: 7814642000
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Phone: 7814642000
Mailing address:
225 BINNEY STREET, CAMBRIDGE, MA, 02142
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Category:
Large accelerated filer
Large accelerated filer
Former names:
- BIOGEN IDEC INC. - filings through 2015-03-20
- BIOGEN IDEC INC - filings through 2007-04-25
- IDEC PHARMACEUTICALS CORP / DE - filings through 2003-11-12
- IDEC PHARMACEUTICALS CORP / CA - filings through 1997-02-14
Filings:
2,597 EDGAR filings since May 21, 1996
2,597 EDGAR filings since May 21, 1996
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 7, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 12, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 12, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 15, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- January 10, 2025 - SCHEDULE 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- February 12, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- January 15, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 12, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- October 30, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 1, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- April 24, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 26, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- April 12, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 10, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 10, 2025 - 3: Initial statement of beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 12, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- January 10, 2025 - SCHEDULE 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 12, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 7, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 1,008 entries
Data source:
CIK0000875045.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
